Carl Zeiss AG, Johnson & Johnson Surgical Vision, Inc. (A subsidiary of Johnson & Johnson Services, Inc.) are Dominating the Europe Refractive Surgery Devices Market in 2019

Europe Refractive Surgery Devices Market is expected to grow with the CAGR of 6.6% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report at https://www.databridgemarketresearch.com/reports/europe-refractive-surgery-devices-market

Europe refractive surgery devices market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.   

The major players dealing in refractive surgery devices market are introducing strong range of products provider along with receiving large number of CE mark approvals for launching new products into the market. For instance, In October 2017, Johnson & Johnson Surgical Vision, Inc introduced their CE mark approval iDESIGN Refractive Studio in the European Society of Cataract & Refractive Surgeons (ESCRS). This new system has capability to capture 1,200 micro readings of the eye. By showcasing such advance product in European Society of Cataract & Refractive Surgeons, the company enhanced their credibility in the market.

Carl Zeiss AG is the dominating player in refractive surgery devices market. The other key players existing in the market includes Hoya Surgical Optics, Schwind Eye-Tech-Solutions, Rayner Intraocular Lenses Limited., Ziemer Ophthalmic Systems, Nidek CO., LTD. Lensar, Inc., Ivis Technologies, Oculentis, Lenstec, Inc., Staar Surgical, OPHTEC, BV, Bausch + Lomb Incorporated, Johnson & Johnson Surgical Vision, Inc.(A subsidiary of Johnson & Johnson Services, Inc.), and Alcon Inc. among others.  

Alcon INC

Alcon INC, headquartered in Geneva, Switzerland which was founded in 1945. The company focuses on providing innovation technology to transform eye diseases and eye conditions. The company has multiple business segments vision care and surgical, surgical is the market focused segments. Company also has wide product portfolio ocular health, contact lenses & solutions, refractive technology, cataract surgery, vitreoretinal surgery, in this refractive technology is the market focused category.  

• In September 2019, Alcon, Inc. announced that they have upgraded their product WaveLight by making additions in its WaveLight Refractive Suite to support the performance of LASIK surgery. The Phorcides is Analytic Engine diagnostic software that helps to analyze the topographic treatment for an eye. By upgrading their product, the company has increased the credibility and product portfolio of their products in the market.

The company has presence in North America, Europe, South America, Middle East, Asia-Pacific and Africa. The company also has various subsidiary companies such as Alcon Pharmaceuticals Ltd. (Switzerland), Alcon Vision, LLC (U.S.), Alcon Laboratories, Inc. (U.S.) and among others.

Carl Zeiss AG

Carl Zeiss AG, headquartered in Jena, Germany which was founded in 2002. The company provides complete solutions in the diagnosis of ophthalmic diseases, which involves intraoperative radiotherapies. The company has multiple business segments ophthalmic devices and microsurgery, in which ophthalmic devices is the market focused segments. Company also has wide product portfolio in medical technology, microscopy, vision care, industrial metrology, spectroscopy, photography, cinematography, hunting, nature observation, simulation solutions, development/production services, planetariums, semiconductor manufacturing technologies, in this medical technology is the market focused product category.

• In April 2017, Carl Zeiss Meditec launched the new barrett suite Into IOLMaster.  It is a latest and advance generation based Barrett IOL power calculation formulas. The new Barrett Suite consists of the Barrett Universal II, Barrett True-K and Barrett Toric.  These formulas are automatically applied on IOLMaster 700 system depending on the IOL selected and the refractive surgery status of the patient.

The company has presence in North America, South America, Europe, Middle East and Africa, Asia-Pacific The company also has various subsidiary companies such as Carl Zeiss Surgical GmbH (Germany), Carl Zeiss Meditec, Inc. (U.S.), Carl Zeiss N.V.(Belgium), Carl Zeiss Co. Ltd., South Korea(South Korea), and among others.

Johnson & Johnson Surgical Vision, Inc. (A subsidiary of Johnson & Johnson Services, Inc.)

Johnson & Johnson Surgical Vision, Inc. (A subsidiary of Johnson & Johnson Services, Inc.) is headquartered in California, U.S. was founded in 1943. The company engaged in manufacturing and commercialization of eye care products for improving global health. The company engaged in providing wide range of products category contact lens products, ocular surface care, surgical products, in these surgical products is the market focused category.

• In September 2018, Johnson & Johnson Surgical Vision, Inc has launched the iDESIGN Refractive Studio which is a next generation of personalized LASIK treatment. This product is received approval for the surgery of myopia, mixed astigmatism and hyperopia.

The company has global presence in North America, Europe and Asia-Pacific.